Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAAR: Sertraline and CBT for Anxiety in Autism Spectrum Disorder
NCT03279471Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Oct 2017
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sertraline in anxiety disorder (3 arms), sponsored by University of California, Davis. Primary endpoint: Pediatric Anxiety Rating Scale at 17 weeks. Started Oct 2017; status: completed.
02
Drugs
sertraline
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT03279471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03279471.